The challenges of flow cytometry: an interview with David Lanham
In this Bioanalysis Zone interview, David Lanham (Eurofins BioPharma Services; MO, USA) discusses his work using flow cytometry for pharmacodynamic biomarker analysis and receptor engagement in early clinical stage work. David also explains the challenges faced when using flow cytometry as an analytical tool, before sharing his thoughts on the progress that has been made to regulate and standardize the field.
If you are interested in flow cytometry, you might also like…
Interview with David Lanham (Eurofins) on flow cytometry in bioanalysis
Flow cytometry: a flexible tool for biomarker research
